What Acorda Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Cohen Ron | President and CEO | Mar 17 | Open-market buy · P | +10,000 | $0.65 | +$6.5K | 149,757 |
| Cohen Ron | President and CEO | Mar 16 | Open-market buy · P | +10,156 | $0.60 | +$6.09K | 139,757 |
| Clem Kerry M | Chief Commercial Officer | Sep 03 | Withheld — tax / exercise cost · F | −1,511 | $0.40 | −$601 | 10,083 |
| Sabella Lauren M | Chief Operating Officer | Sep 03 | Withheld — tax / exercise cost · F | −1,511 | $0.40 | −$601 | 10,710 |
| Cohen Ron | President and CEO | Mar 17 | Sale for tax withholding · S | −2,289 | $1.70 | −$3.89K | 129,601 |
| Cohen Ron | President and CEO | Sep 03 | Withheld — tax / exercise cost · F | −3,940 | $4.38 | −$17.3K | 131,890 |
| Morales Robert | Interim PAO & PFO | Sep 03 | Withheld — tax / exercise cost · F | −448 | $4.38 | −$1.96K | 4,423 |
| Sabella Lauren M | Chief Commercial Officer | Sep 03 | Withheld — tax / exercise cost · F | −1,511 | $4.38 | −$6.62K | 12,221 |
| Sabella Lauren M | Chief Commercial Officer | Mar 03 | Grant / award · A | +11,125 | — | — | 13,732 |
| Blank Burkhard | CMO and Head of R&D | Mar 03 | Grant / award · A | +11,125 | — | — | 18,527 |
| Cohen Ron | President and CEO | Mar 03 | Grant / award · A | +29,000 | — | — | 135,830 |
| Lawrence David | Chief, Bus. Ops & PAO | Dec 01 | Withheld — tax / exercise cost · F | −1,141 | $0.65 | −$738 | 13,811 |
| Lawrence David | Chief, Bus. Ops & PAO | Nov 09 | Withheld — tax / exercise cost · F | −1,024 | $0.86 | −$881 | 14,952 |
| Lawrence David | Chief, Bus. Ops & PAO | Sep 17 | Grant / award · A | +3,015 | — | — | 15,976 |
| Blank Burkhard | CMO and Head of R&D | Sep 17 | Grant / award · A | +3,015 | — | — | 44,410 |
| Cohen Ron | President and CEO | Sep 17 | Grant / award · A | +8,543 | — | — | 640,980 |
| Sabella Lauren M | Chief Commercial Officer | Sep 17 | Grant / award · A | +3,015 | — | — | 15,639 |
| Wasman Jane | President, Intl and GC | Dec 02 | Sale for tax withholding · S | −2,227 | $1.60 | −$3.55K | 117,420 |
| Lawrence David | Chief, Bus. Ops & PAO | Dec 02 | Sale for tax withholding · S | −1,176 | $1.60 | −$1.88K | 12,961 |
| Cohen Ron | President and CEO | Dec 02 | Sale for tax withholding · S | −4,699 | $1.60 | −$7.51K | 607,287 |
Loading...
